(2026). Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis. Rheumatology & Autoimmunity.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Impact of Biological/targeted Versus Conventional Synthetic Disease‐modifying Antirheumatic Drugs on Patient‐reported Outcomes in Rheumatoid Arthritis."
Rheumatology & Autoimmunity 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Impact of Biological/targeted Versus Conventional Synthetic Disease‐modifying Antirheumatic Drugs on Patient‐reported Outcomes in Rheumatoid Arthritis."
Rheumatology & Autoimmunity, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.